http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5283665-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_630b360599ea5cf4b5bcbc0c6c0a3e2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_767099222da7ce6d35d8227cdee4ae8c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
filingDate 1976-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeda8b1e8a17080884ce1143bf4a276d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a6224194bcfaf9638cdf00e52e626a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1db47e6b125fbaa6e3681c7e01d6027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_444ec60638f5d3baafc9875c3ce44b2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a4f1bc36eaa1a5dc30996ed0784f267
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_984ac0c98a68e8fcaf870f05ecabb882
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31402abe784ae18a7dc823bd3dbb58e5
publicationDate 1977-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5283665-A
titleOfInvention Ng-substituted-n2-coumarinsulfonylargininamides -coumarins and their acid salts
abstract PURPOSE: NG-Substituted-N 2 -coumarinsulfonylargininamides of the formula I [one of X and Y is a protective group of a guanidino group, and the other is H or a protective group of the guanidino group; R is-NR 1 R 2 (R 1 and R 2 are H, alkyl, aralkyl, etc.) or a cyclic amino group (e.g. 1-polymethyleneiminyl, 3oxazolidinyl, morpholino, etc.); and R' is H or alkyl], and their acid salts. For example, 4-ethyl-1-(NG-nitro-N 2 -(6-coumarinsulfonyl)-L-arginyl) piperidine may be cited. n COPYRIGHT: (C)1977,JPO&Japio
priorityDate 1976-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410207
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429380971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456144919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54688261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153877898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457472442

Total number of triples: 36.